WCM Investment Management
TEVA icon

WCM Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

WCM Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38B Buy
41,315,232
+494,632
+1% +$16.5M 2.5% 11
2026
Q1 		$1.16B Buy
40,820,600
+26,813,522
+191% +$863M 2.64% 13
2025
Q4 		$439M Buy
14,007,078
+13,756,631
+5,493% +$339M 0.9% 37
2025
Q3 		$4.8M Buy
250,447
+35,691
+17% +$627K 0.01% 167
2025
Q2 		$3.6M Buy
214,756
+1,599
+0.8% +$25.8K 0.01% 168
2025
Q1 		$3.21M Buy
213,157
+77,403
+57% +$1.38M 0.01% 204
2024
Q4 		$3.03M Buy
135,754
+75,584
+126% +$1.38M 0.01% 210
2024
Q3 		$1.05M Buy
+60,170
New +$1.05M ﹤0.01% 252

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WCM Investment Management's TEVA Position: Q2 2026 in Review

WCM Investment Management increased its Teva Pharmaceuticals (TEVA) stake by 1.2% in Q2 2026, buying an estimated $16.5M and bringing the position to 41,315,232 shares worth $1.38B. The position accounts for 2.5% of the portfolio, ranked #11.

WCM Investment Management first reported a position in TEVA in Q3 2024 and has held it in 8 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • WCM Investment Management held 41,315,232 shares of Teva Pharmaceuticals worth $1.38B as of Q2 2026.
  • WCM Investment Management bought 494,632 Teva Pharmaceuticals shares in Q2 2026, an estimated $16.5M.
  • Teva Pharmaceuticals made up 2.5% of WCM Investment Management's portfolio in Q2 2026, its #11 holding.
  • WCM Investment Management first reported a position in Teva Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on WCM Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.